Steward Partners Investment Advisory, LLC Aeterna Zentaris Inc. Transaction History

Steward Partners Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$0.59 - $0.88 $5,900 - $8,800	-10,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$0.83 - $1.14 $8,294 - $11,392	9,993 Added 142757.14%	10,000 $9,000
Q1 2021 May 14, 2021	BUY	$0.51 - $3.34 $3 - $23	7 New	7 $0
Q4 2018 Jan 15, 2019	SELL	$1.3 - $3.87 $5 - $15	-4 Closed	0 $0
Q2 2018 Jul 20, 2018	BUY	$1.19 - $2.62 $4 - $10	4 New	4 $0

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.